An operating system for modern psychotherapy - combining care structures and technology within regulated healthcare for better results.
Sympatient has raised $7.4M in total funding. The most recent round was Series A. The last funding was announced in September 2022.
Sympatient's investors include Verve Ventures, Kinled Holding, Investitions- und Förderbank.
Sympatient is headquartered in Hamburg, Germany.
An operating system for modern psychotherapy - combining care structures and technology within regulated healthcare for better results.
Sympatient is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sympatient — Funding & Investors." VCBacked, September 29, 2022, https://www.vcbacked.co/company/sympatient. Accessed July 19, 2026.
VCBacked. (2022). Sympatient — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/sympatient
{{cite web |title=Sympatient — Funding & Investors |url=https://www.vcbacked.co/company/sympatient |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated